"disease progression" trang 5 - tải miễn phí từ tailieunhanh
Altered staining patterns and expression level of Engrailed-2 in benign prostatic hyperplasia and prostate cancer predict prostatic disease progression

Altered staining patterns and expression level of Engrailed-2 in benign prostatic hyperplasia and prostate cancer predict prostatic disease progression
13    36    1
Amplification and up-regulation of MIR30D was associated with disease progression of cervical squamous cell carcinomas

Amplification and up-regulation of MIR30D was associated with disease progression of cervical squamous cell carcinomas
11    66    1
Down-regulated expression of OPCML predicts an unfavorable prognosis and promotes disease progression in human gastric cancer

Down-regulated expression of OPCML predicts an unfavorable prognosis and promotes disease progression in human gastric cancer
10    40    1
Prognostic value of platelet recovery degree before and after achieving minimal residual disease negative complete remission in acute myeloid leukemia patients

Prognostic value of platelet recovery degree before and after achieving minimal residual disease negative complete remission in acute myeloid leukemia patients
8    34    1
Rechallenge and maintenance therapy using cetuximab and chemotherapy administered to a patient with metastatic colorectal cancer

Rechallenge and maintenance therapy using cetuximab and chemotherapy administered to a patient with metastatic colorectal cancer
5    83    1
Predicting clinical outcomes in chordoma patients receiving immunotherapy: A comparison between volumetric segmentation and RECIST

Predicting clinical outcomes in chordoma patients receiving immunotherapy: A comparison between volumetric segmentation and RECIST
9    47    1
Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients?

Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients?
11    58    1
Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis

Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis
10    55    1
Changes in mitochondrial stability during the progression of the Barrett’s esophagus disease sequence

Changes in mitochondrial stability during the progression of the Barrett’s esophagus disease sequence
9    66    1
Post-crizotinib management of effective ceritinib therapy in a patient with ALKpositive non-small cell lung cancer

Post-crizotinib management of effective ceritinib therapy in a patient with ALKpositive non-small cell lung cancer
5    61    1
MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: Study on C57BL/6J mice

MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: Study on C57BL/6J mice
14    49    1
DocOx (AIO-PK0106): A phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinoma

DocOx (AIO-PK0106): A phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinoma
9    66    1
A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancer

A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancer
8    44    1
Plasma-based longitudinal mutation monitoring as a potential predictor of disease progression in subjects with adenocarcinoma in advanced non-small cell lung cancer

Plasma-based longitudinal mutation monitoring as a potential predictor of disease progression in subjects with adenocarcinoma in advanced non-small cell lung cancer
9    75    1
Blood transcript analysis and metastatic recurrent small bowel carcinoid management

Blood transcript analysis and metastatic recurrent small bowel carcinoid management
5    34    1
Circulating MicroRNA-21-3p: A potential biomarker for peste-des petits ruminants virus in naturally infected goats

Circulating MicroRNA-21-3p: A potential biomarker for peste-des petits ruminants virus in naturally infected goats
11    32    1
A multicenter phase II study of everolimus in patients with progressive unresectable adenoid cystic carcinoma

A multicenter phase II study of everolimus in patients with progressive unresectable adenoid cystic carcinoma
6    33    1
MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression

MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression
8    34    1
FOXP1 inhibits cell growth and attenuates tumorigenicity of neuroblastoma

FOXP1 inhibits cell growth and attenuates tumorigenicity of neuroblastoma
16    27    1
Predicting response to vascular endothelial growth factor inhibitor and chemotherapy in metastatic colorectal cancer

Predicting response to vascular endothelial growth factor inhibitor and chemotherapy in metastatic colorectal cancer
14    75    1